top of page


  1. Van der Zee AG, Oonk MH, De Hullu JA, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008; 26: 884-889. CrossrefPubMedWeb of Science®GoogleScholar

  2.  Moore RG, Robison K, Brown AK, et al. Isolated sentinel lymph node dissection with conservative management in patients with squamous cell carcinoma of the vulva: a prospective trial. Gynecol Oncol. 2008; 109: 65-70; comment 2008;111:158; author reply 2008;111:159. CrossrefPubMedWeb of Science®Google Scholar

  3.  Zhang X, Sheng X, Niu J, et al. Sparing of saphenous vein during inguinal lymphadenectomy for vulval malignancies. Gynecol Oncol. 2007; 105: 722-726. CrossrefPubMedWeb of Science®GoogleScholar

  4.  Bellati F, Angioli R, Manci N, et al. Single agent cisplatin chemotherapy in surgically resected vulvar cancer patients with multiple inguinal lymph node metastases. Gynecol Oncol. 2005; 96: 227-231. CrossrefCASPubMedWeb of Science®Google Scholar

  5.  Judson PL, Jonson AL, Paley PJ, et al. A prospective, randomized study analyzing sartorius transposition following inguinal-femoral lymphadenectomy. Gynecol Oncol. 2004; 95: 226-230. CrossrefPubMedWeb of Science®Google Scholar

  6.  Gaarenstroom KN, Kenter GG, Trimbos JB, et al. Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions. Int J Gynecol Cancer. 2003; 13: 522-527. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar

  7.  de Hullu JA, Ansink AC, Tymstra T, van der Zee AG. What doctors and patients think about false-negative sentinel lymph nodes in vulvar cancer. J Psychosom Obstet Gynecol. 2001; 22: 199-203. CrossrefCASPubMedWeb of Science®Google Scholar

  8.  Holmes EC, Moseley HS, Morton DL, Clark W, Robinson D, Urist MM. A rational approach to the surgical management of melanoma. Ann Surg. 1977; 186: 481-490. CrossrefPubMedWeb of Science®Google Scholar

  9.  Ravi R. Morbidity following groin dissection for penile carcinoma. Br J Urol. 1993; 72: 941-945. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar

  10.  de Vries M, Vonkeman WG, van Ginkel RJ, Hoekstra HJ. Morbidity after axillary sentinel lymph node biopsy in patients with cutaneous melanoma. Eur J Surg Oncol. 2005; 31: 778-783. CrossrefPubMedWeb of Science®Google Scholar

  11.  de Vries M, Vonkeman WG, van Ginkel RJ, Hoekstra HJ. Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma. Eur J Surg Oncol. 2006; 32: 785-789. CrossrefPubMedWeb of Science®GoogleScholar

  12. Baas PC, Schraffordt Koops H, Hoekstra HJ, van Bruggen JJ, van der Weele LT, Oldhoff J. Groin dissection in the treatment of lower-extremity melanoma. Short-term and long-term morbidity. Arch Surg. 1992; 127: 281-286. CrossrefCASPubMedWeb of Science®Google Scholar

  13.  James JH. Lymphoedema following ilio-inguinal lymph node dissection. Scand J Plast Reconstruct Surg. 1982; 16: 167-171. CrossrefCASPubMedWeb of Science®Google Scholar

  14.  Starritt EC, Joseph D, McKinnon JG, et al. Lymphedema after complete axillary node dissection for melanoma: assessment using a new, objective definition. Ann Surg. 2004; 240: 866-874. CrossrefPubMedWeb of Science®Google Scholar

  15. Common Toxicity Criteria. Cancer Therapy Evaluation Program, 1999. Available at: Accessed April 30, 1999.Google Scholar

  16.  Rubin P, Constine LS III, Fajardo LF, Phillips TL, Wasserman TH. EORTC Late Effects Working Group. Overview of late effects normal tissues (LENT) scoring system. Radiother Oncol. 1995; 35: 9-10. CrossrefCASPubMedWeb of Science®Google Scholar

  17.  Bergmark K, Avall-Lundqvist E, Dickman PW, et al. Patient-rating of distressful symptoms after treatment for early cervical cancer. Acta Obstet Gynecol Scand. 2002; 81: 443-450. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar

  18.  Bilek K, Ebeling K, Leitsmann H, Seidel G. Radical pelvic surgery versus radical surgery plus radiotherapy for stage Ib carcinoma of the cervix uteri. Preliminary results of a prospective randomized clinical study. Archiv fur Geschwulstforschung. 1982; 52: 223-229. CASPubMedWeb of Science®Google Scholar

  19.  Chatani M, Nose T, Masaki N, Inoue T. Adjuvant radiotherapy after radical hysterectomy of the cervical cancer. Prognostic factors and complications. Strahlenther Onkol. 1998; 174: 504-509. CrossrefCASPubMedWeb of Science®Google Scholar

  20.  Gelman A. Bayesian Data Analysis. 2nd ed. Boca Raton, FL: Chapman & Hall/CRC; 2004. Google Scholar

  21. Spiegelhalter D, Thomas A, Best N. WINBUGS Version 1.4 User Manual: MRC Biostatistics Unit; 2003. Google Scholar 

  22. Gelman A, Rubin D. Inference from iterative simulation using multiple sequences. Stat Sci. 1992; 7: 457-511. CrossrefGoogleScholar 

  23. Bowsher WG, Taylor BA, Hughes LE. Morbidity, mortality and local recurrence following regional node dissection for melanoma. Br J Surg. 1986; 73: 906-908. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar

  24. Burmeister BH, Smithers BM, Davis S, et al. Radiation therapy following nodal surgery for melanoma: an analysis of late toxicity. ANZ J Surg. 2002; 72: 344-348. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar

  25. Lawton G, Rasque H, Ariyan S. Preservation of muscle fascia to decrease lymphedema after complete axillary and ilioinguinofemorallymphadenectomy for melanoma. J Am Coll Surg. 2002; 195: 339-351. CrossrefPubMedWeb of Science®Google Scholar

  26. Serpell JW, Carne PW, Bailey M. Radical lymph node dissection for melanoma. ANZ J Surg. 2003; 73: 294-299. Wiley Online LibraryPubMedWeb of Science®Google Scholar

  27. Urist MM, Maddox WA, Kennedy JE, Balch CM. Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patients. Cancer. 1983; 51: 2152-2156. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar

  28. Wrightson WR, Wong SL, Edwards MJ, et al. Complications associated with sentinel lymph node biopsy for melanoma. Ann Surg Oncol. 2003; 10: 676-680. CrossrefPubMedWeb of Science®Google Scholar

  29. Carlson JW, Kauderer J, Walker JL, et al. A randomized phase III trial of VH fibrin sealant to reduce lymphedema after inguinal lymph node dissection: a Gynecologic Oncology Group study. Gynecol Oncol. 2008; 10: 76-82. CrossrefCASWeb of Science®GoogleScholar

  30. Werngren-Elgstrom M, Lidman D. Lymphoedema of the lower extremities after surgery and radiotherapy for cancer of the cervix. Scand J Plast Reconstruct Surg Hand Surg. 1994; 28: 289-293. CrossrefCASPubMedWeb of Science®Google Scholar

  31. Wolff HA, Overbeck T, Roedel RM, et al. Toxicity of daily low dose cisplatin in radiochemotherapy for locally advanced head and neck cancer. J Cancer Res Clin Oncol. 2009; 135: 961-967. CrossrefCASPubMedWeb of Science®Google Scholar

  32. Robinson MH, Spruce L, Eeles R, et al. Limb function following conservation treatment of adult soft tissue sarcoma. Eur J Cancer. 1991; 27: 1567-1574. CrossrefCASPubMedWeb of Science®Google Scholar

  33. Brouns E, Donceel P, Stas M. Quality of life and disability after ilio-inguinal lymphadenectomy. Acta Chir Belg. 2008; 108: 685-690. CrossrefCASPubMedWeb of Science®Google Scholar

  34. Rockson SG, Rivera KK. Estimating the population burden of lymphedema. Ann N Y Acad Sci. 2008; 1131: 147-154. Wiley Online LibraryPubMedWeb of Science®Google Scholar

  35. Norman SA, Localio AR, Potashnik SL, et al. Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol. 2009; 27: 390-397. CrossrefPubMedWeb of Science®Google Scholar

  36. Morgan PA, Franks PJ, Moffatt CJ. Health-related quality of life with lymphoedema: a review of the literature. Int Wound J. 2005; 2: 47-62. Wiley Online LibraryPubMedWeb of Science®Google Scholar

  37. Shih YC, Xu Y, Cormier JN, et al. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol. 2009; 27: 2007-2014. CrossrefPubMedWeb of Science®Google Scholar

  38. Armer JM. The problem of post-breast cancer lymphedema: impact and measurement issues. Cancer Invest. 2005; 23: 76-83. CrossrefPubMedWeb of Science®Google Scholar

  39. Petrek JA, Heelan MC. Incidence of breast carcinoma-related lymphedema. Cancer. 1998; 83(12 suppl): 2776-2781. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar

  40. Erickson VS, Pearson ML, Ganz PA, Adams J, Kahn KL. Arm edema in breast cancer patients. J Natl Cancer Inst. 2001; 93: 96-111. CrossrefCASPubMedWeb of Science®Google Scholar

  41. McLaughlin SA, Wright MJ, Morris KT, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol. 2008; 26: 5213-5219. CrossrefPubMedWeb of Science®Google Scholar

  42. Borghouts JA, Koes BW, Bouter LM. The clinical course and prognostic factors of non-specific neck pain: a systematic review. Pain. 1998; 77: 1-13. CrossrefCASPubMedWeb of Science®Google Scholar

  43. Kuijpers T, van der Windt DA, van der Heijden GJ, Bouter LM. Systematic review of prognostic cohort studies on shoulder disorders. Pain. 2004; 109: 420-431. CrossrefPubMedWeb of Science®Google Scholar

  44. Scholten-Peeters GG, Verhagen AP, Bekkering GE, et al. Prognostic factors of whiplash-associated disorders: a systematic review of prospective cohort studies. Pain. 2003; 104: 303-322. CrossrefCASPubMedWeb of Science®Google Scholar

  45. Mols F, Vingerhoets AJ, Coebergh JW, van de Poll-Franse LV. Quality of life among long-term breast cancer survivors: a systematic review. Eur J Cancer. 2005; 41: 2613-2619. CrossrefPubMedWeb of Science®Google Scholar

bottom of page